J.Safra Asset Management Corp Has $31.52 Million Stock Holdings in VanEck Pharmaceutical ETF $PPH

J.Safra Asset Management Corp lifted its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 6.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 305,472 shares of the company’s stock after buying an additional 19,685 shares during the period. VanEck Pharmaceutical ETF makes up about 1.7% of J.Safra Asset Management Corp’s holdings, making the stock its 16th largest holding. J.Safra Asset Management Corp’s holdings in VanEck Pharmaceutical ETF were worth $31,516,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. AlphaCore Capital LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter worth about $31,000. IFP Advisors Inc boosted its stake in shares of VanEck Pharmaceutical ETF by 53.7% during the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after buying an additional 153 shares during the last quarter. Advisory Services Network LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the 3rd quarter worth about $41,000. REAP Financial Group LLC acquired a new stake in VanEck Pharmaceutical ETF in the 4th quarter valued at about $52,000. Finally, CWM LLC lifted its stake in VanEck Pharmaceutical ETF by 36.3% in the 4th quarter. CWM LLC now owns 511 shares of the company’s stock valued at $53,000 after purchasing an additional 136 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of NASDAQ:PPH opened at $105.29 on Thursday. VanEck Pharmaceutical ETF has a 52-week low of $81.74 and a 52-week high of $112.58. The company has a market capitalization of $999.20 million, a P/E ratio of 20.21 and a beta of 0.47. The company has a 50-day simple moving average of $102.91 and a 200 day simple moving average of $104.29.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 7th. Shareholders of record on Wednesday, April 1st were issued a $0.8441 dividend. The ex-dividend date of this dividend was Wednesday, April 1st. This represents a $3.38 annualized dividend and a yield of 3.2%. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.